MedPath
FDA Product

cephalexin

Product approved by U.S. Food and Drug Administration (US)

Basic Information

cephalexin

33261-149

Regulatory Information

33261-149

ANDA062791

C73584

September 13, 2012

USA

Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

HUMAN PRESCRIPTION DRUG LABEL

3

Company Information

801503249

Active Ingredients

CEPHALEXIN ANHYDROUS

Quantity: 250 mg in 1 1

Code: 5SFF1W6677

Class Code: ACTIB

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

D&C YELLOW NO. 10

Code: 35SW5USQ3G

Class Code: IACT

SODIUM LAURYL SULFATE

Code: 368GB5141J

Class Code: IACT

FD&C GREEN NO. 3

Code: 3P3ONR6O1S

Class Code: IACT

FD&C YELLOW NO. 6

Code: H77VEI93A8

Class Code: IACT

GELATIN

Code: 2G86QN327L

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

Active Moieties

CEPHALEXIN ANHYDROUS

Code: 5SFF1W6677

© Copyright 2025. All Rights Reserved by MedPath